Attempts to target antibody-ricin conjugates (immunotoxins) to designated cell types in vivo may be thwarted by their rapid clearance by hepatic reticuloendothelial cells which have receptors that recognise oligosaccharide side chains on the toxin. The B-chain of ricin contains high mannose type oligosaccharides and the A-chain contains a complex unit (GlcNAc)2-Fuc-Xyl-(Man)4-6, all of which potentially could be recognised by the reticuloendothelial system.Treatment of ricin with a mixture of sodium metaperiodate and sodium cyanoborohydride at pH 3.5 resulted in oxidative cleavage of the carbohydrates and reduction of the aldehyde groups thus formed to primary alcohols. By conducting the modification procedure at acidic pH, both the possibility of Schiff s base formation between the aldehyde groups and amino groups in the protein and the possibility of non-specific oxidation of amino acids were minimised. The extent of the carbohydrate modification depended on the duration of treatment, resulting maximally in the destruction of 13 of the 18 mannose residues and of all xylose and fucose.The toxicity of the modified toxin to cells in culture declined by up to 90% as the carbohydrate was destroyed. This was not due to a reduced ability of the B-chain to bind to cells or of the A-chain to inactivate ribosomes. In contrast to the in vitro results, the toxicity of the modified toxin to mice and rats was elevated by up to fourfold. The modification greatly reduced the clearance of the toxin by non-parenchymal cells in the liver and prevented the damage to hepatic Kupffer and sinusoidal cells and to the red pulp of the spleen that is inflicted by the native toxin. The elevated toxicity to animals appears to be because the modified toxin evades the reticuloendothelial system and persists in the bloodstream for longer periods, thus resulting in lethal damage to vital tissues in the animal at lower dosage.The results suggest that immunotoxins prepared from modified ricin would not be readily cleared by the reticuloendothelial system and so be more effective at killing their target cells.Attempts have been made in several laboratories to target ricin to designated cell types in animals by linking it to specific antibodies (reviewed in [l -31).Ricin, the toxin from the castor bean, is a glycoprotein comprising two polypeptide chains, A and B, joined by a disulphide bond. The B-chain binds to galactose-containing glycoproteins and glycolipids on cell surfaces and the A-chain then penetrates the membrane (probably from an endocytic vesicle) and kills the cell by inactivating ribosomes (reviewed in 141).When injected intravenously into rats or mice, rich rapidly accumulates in the liver and, to a lesser extent, in the spleen [5] wise be cleared from the bloodstream in animals and prompted us to devise ways of modifying the carbohydrate side chains in the toxin to prevent hepatic recognition. A previous attempt by Simeral et al. [8] to destroy the carbohydrate in ricin using sodium metaperiodate resulted in virtually complete ...